TH
Therapeutic Areas
Ellodi Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| APT-1011 | Eosinophilic Esophagitis (EoE) | Phase 3 |
Leadership Team at Ellodi Pharmaceuticals
DG
Dr. Gina Eagle
Vice President, Research and Development
SM
Sarah Murchison
Chief Operating Officer
KK
Karol Knoop, RN, BS
Senior Director, Clinical and Medical Affairs Operations
VK
Vered Katz Ben-Yair
Head of Program Management